Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Recruiting 32Not yet recruiting 15Active not recruiting 7Completed 4Unknown 3Withdrawn 1Terminated 1Enrolling by invitation 1

Sponsor Class

INDUSTRY 15OTHER 4

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Breast 4CNS 2

Conditions

Breast Neoplasms 4Neoplasm Metastasis 2Brain Neoplasms 2Meningeal Carcinomatosis 1

Interventions

Cyclophosphamide 956Radiotherapy 847Cisplatin 757Gemcitabine 657Carboplatin 603Docetaxel 598Paclitaxel 585Bevacizumab 580Fluorouracil 504Oxaliplatin 458Rituximab 453Surveys and Questionnaires 449Capecitabine 440Dexamethasone 428Doxorubicin 424Etoposide 411Irinotecan 389Cytarabine 376Filgrastim 369pembrolizumab 330Leucovorin 305Nivolumab 296fludarabine phosphate 294Melphalan 288Magnetic Resonance Spectroscopy 281Peripheral Blood Stem Cell Transplantation 279Blood Specimen Collection 279Methotrexate 276Lenalidomide 276Cetuximab 270

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × OTHER × trastuzumab deruxtecan × Clear all
NCT06504719 2025-09-15

Safety and Efficacy Real-world Data of Trastuzumab Deruxtecan and Sacituzumab Govitecan

Hellenic Cooperative Oncology Group

Completed
312 enrolled
BreastCNS

Brain Neoplasms, Breast Neoplasms, Neoplasm Metastasis

NCT04420598 2025-06-24

DEBBRAH

MedSIR

Phase 2 Completed
41 enrolled 32 charts
BreastCNS

Brain Neoplasms, Breast Neoplasms, Neoplasm Metastasis, Meningeal Carcinomatosis

NCT04132960 2025-06-12

DAISY

UNICANCER

Phase 2 Completed
186 enrolled
Breast

Breast Neoplasms

NCT04752059 2023-05-12

TUXEDO-1

Medical University of Vienna

Phase 2 Completed
15 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡